Pharmaco-EEG: from cellular to the network level. EEG beta spectral power as a biomarker for GABAergic inhibition and its role in the assessment of AEDs.
Lopes da Silva
F
F
Section of Neurobiology, Swammerdam Institute for Life Sciences, University of Amsterdam, Foundation of Epilepsy Clinics of  The Netherlands, Heemstede, The Netherlands.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D015415:Biomarkers / Q000032:analysis; D004569:Electroencephalography / Q000187:drug effects* / Q000379:methods; D006801:Humans; D009433:Neural Inhibition / Q000502:physiology*; D018079:Receptors, GABA / Q000502:physiology*; D013678:Technology, Pharmaceutical / Q000379:methods
D000927:Anticonvulsants; D015415:Biomarkers; D018079:Receptors, GABA